Holtkamp Kim C A, Mathijssen Inge B, Lakeman Phillis, van Maarle Merel C, Dondorp Wybo J, Henneman Lidewij, Cornel Martina C
Department of Clinical Genetics, Section of Community Genetics and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands.
Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands.
Eur J Public Health. 2017 Apr 1;27(2):372-377. doi: 10.1093/eurpub/ckw110.
Carrier screening for autosomal recessive disorders aims to facilitate reproductive decision-making by identifying couples with a 1-in-4 risk in every pregnancy of having an affected child. Except for a few countries or regions, carrier screening is not widely offered and is mostly ancestry-based. Technological advances enable carrier screening for multiple diseases simultaneously allowing universal screening regardless of ancestry (population-based expanded carrier screening). It is important to study how this can be successfully implemented. This study therefore aims to identify critical factors involved in successful implementation, from a user perspective, by learning from already implemented initiatives.
Factors associated with successful implementation were identified by: (i) a literature review and (ii) two case studies; studying experiences with carrier screening in two high-risk communities (a Dutch founder population and the Ashkenazi Jewish population), including a survey among community members.
Factors identified were familiarity with (specific) genetic diseases and its availability, high perceived benefits of screening (e.g. screening avoids much suffering), acceptance of reproductive options, perceived risk of being a carrier and low perceived social barriers (e.g. stigmatization). In contrast to the Jewish community, the initial demand for screening in the Dutch founder population did not entirely come from the community itself. However, the large social cohesion of the community facilitated the implementation process.
To ensure successful implementation of population-based expanded carrier screening, efforts should be made to increase knowledge about genetic diseases, create awareness and address personal benefits of screening in a non-directive way.
常染色体隐性疾病的携带者筛查旨在通过识别每一次怀孕都有四分之一几率生育患病子女的夫妇,来促进生育决策。除少数国家或地区外,携带者筛查并未广泛开展,且大多基于血统。技术进步使得能够同时对多种疾病进行携带者筛查,从而实现不分血统的普遍筛查(基于人群的扩展携带者筛查)。研究如何成功实施这一筛查非常重要。因此,本研究旨在从用户角度出发,通过借鉴已实施的举措,确定成功实施所涉及的关键因素。
通过以下方式确定与成功实施相关的因素:(i)文献综述和(ii)两个案例研究;研究两个高危群体(一个荷兰奠基人群体和阿什肯纳兹犹太人群体)的携带者筛查经验,包括对群体成员的调查。
确定的因素包括对(特定)遗传疾病的熟悉程度及其可及性、对筛查的高预期益处(例如筛查可避免许多痛苦)、对生育选择的接受度、对成为携带者的感知风险以及低感知社会障碍(例如污名化)。与犹太群体不同,荷兰奠基人群体对筛查的最初需求并非完全来自群体自身。然而,该群体强大的社会凝聚力促进了实施过程。
为确保基于人群的扩展携带者筛查成功实施,应努力增加对遗传疾病的了解,提高认识,并以非指导性方式阐述筛查的个人益处。